Send PM
Followers 17
Posts 1893
Boards Moderated 0
Alias Born 11/13/2013

Re: johnking29 post# 295587

Thursday, 09/03/2020 11:17:16 AM

Thursday, September 03, 2020 11:17:16 AM

Post# of 395339
From PR:

"Amarin anticipates that generics companies, when they launch in the United States, are likely to have limited supply capacity for VASCEPA. Based on this assumption and given the need for greater awareness of VASCEPA by healthcare professionals and at-risk patients, Amarin intends to continue current promotion levels of VASCEPA in the United States. After assessing the scope, timing and pricing of potential generic competition, Amarin will decide whether to further expand, contract or maintain such levels of VASCEPA promotion."

Big mistake. Shit can the DTC and shit can the sales force. JT is gonna bleed this company dry. Watch and see. Also, gear up for another dilution (big one at these prices)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent AMRN News

FEATURED Music Licensing, Inc. (OTC: SONG) Owner of Pro Music Rights One of the World's Largest Music Licensing Companies, Announces That It will explore a forward stock split Dec 9, 2022 11:00 AM

Right On Brands Forms Endo Franchise Group Inc. RTON Dec 9, 2022 8:00 AM

Maison Luxe Provides Update for Investment Holding, Aether Diamonds, The World's Only Carbon-Negative Diamond Producer MASN Dec 8, 2022 11:30 AM

B2Digital to Launch B2 Sports Network (B2SN) Combat Sports Streaming Channel in $90B Streaming BTDG Dec 8, 2022 10:35 AM

Mullen Hires Donald Borthwick as Vice President of Commercial Sales; Previously Head of Western Region for Ford Commercial Sales MULN Dec 8, 2022 8:30 AM

Worldwide Crypto Based Exchange Traded Products AUM Dropped 17% in November FNQQF Dec 7, 2022 8:55 AM

Branded Legacy, Inc. Adds Subsidiary Bringing Additional $750,000 in Revenues BLEG Dec 7, 2022 8:00 AM

BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem Targeting Polycystic Ovary Syndrome as an Indication BRTX Dec 6, 2022 9:52 AM

Maison Luxe Announces Additional $250,000 Purchase Order from Signet International Group for Upcoming Holiday Season MASN Dec 6, 2022 8:10 AM

$10.97 Billion Potential Global Condom Market Could be a Key Driver of Growth for Israeli Cannabis Technology Company BYND Cannasoft Enterprises BYND Dec 5, 2022 8:00 AM

Electromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022 EMED Dec 5, 2022 7:15 AM

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom BYND Dec 2, 2022 10:38 AM

Healixa Inc. Appoints Former Acting Secretary of Defense of The United States Christopher C. Miller to Its Advisory Board EMOR Dec 1, 2022 9:20 AM

Kona Gold Beverage, Inc's Gold Leaf Distribution Subsidiary Posts Record Revenue Month in November KGKG Dec 1, 2022 9:00 AM

Mullen Automotive Officially Closes on Acquisition of ELMS Assets, Takes Possession of Plant in Mishawaka, Ind., All Intellectual Property and Related Inventory MULN Dec 1, 2022 8:31 AM